Tag: CLLSLL
Phase II Study of Orelabrutinib in Patients with R/R CLL/SLL Published...
American Journal of Hematology recently published the phase 2 study result of BTK (Bruton Tyrosine Kinase) inhibitor orelabrutinib in Relapsed or Refractory Chronic...